IQVIA Whitepaper on Improving Diabetes Care in Europe With Insulin Smart Pens Now Available

A recent IQVIA whitepaper discusses improving access to insulin in Europe using smart pens. Ongoing challenges continue to negatively affect the outcomes of people with diabetes (PwD), making this a timely conversation. The paper discusses key strategies for diverse stakeholders, including legislators, regulators, providers, and pharma.

“This report reviews the unmet needs of PwD and takes a look at how smart insulin pens can address some of the difficulties of self-management and improve outcomes. It identifies and assesses the three main challenges that need to be overcome in order for smart pens to reach their full potential for PwD.” Read more here.

(Source: IQVIA, 8/17/21)